1. Home
  2. EW vs BDX Comparison

EW vs BDX Comparison

Compare EW & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$88.97

Market Cap

48.9B

Sector

Health Care

ML Signal

HOLD

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

HOLD

Current Price

$176.03

Market Cap

43.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EW
BDX
Founded
1958
1897
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.9B
43.0B
IPO Year
1999
1998

Fundamental Metrics

Financial Performance
Metric
EW
BDX
Price
$88.97
$176.03
Analyst Decision
Buy
Buy
Analyst Count
21
13
Target Price
$96.37
$186.00
AVG Volume (30 Days)
5.0M
1.7M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
2.89%
EPS Growth
N/A
N/A
EPS
1.07
0.25
Revenue
$6,067,600,000.00
$21,840,000,000.00
Revenue This Year
$13.39
N/A
Revenue Next Year
$9.81
$3.02
P/E Ratio
$83.48
$708.28
Revenue Growth
11.55
8.24
52 Week Low
$72.30
$140.11
52 Week High
$96.29
$213.08

Technical Indicators

Market Signals
Indicator
EW
BDX
Relative Strength Index (RSI) 55.32 72.34
Support Level $81.88 $163.44
Resistance Level $96.29 $196.05
Average True Range (ATR) 2.26 3.72
MACD 0.47 1.47
Stochastic Oscillator 78.41 96.76

Price Performance

Historical Comparison
EW
BDX

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About BDX Becton Dickinson and Company

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Share on Social Networks: